B. Braun Medical Inc. recalled 26,316 bags of Sterile Water for Injection on August 26, 2025. The recall affects the 3000 mL product due to potential fluid leakage from a misaligned port. Consumers should stop using the product immediately and seek guidance from healthcare providers.
Lack of Assurance of Sterility- Potential for fluid leakage from the port due to port misalignment.
Consumers and healthcare providers should stop using this product immediately. Contact B BRAUN MEDICAL INC or your healthcare provider for guidance. Notification method: Letter
Get instant alerts for Health & Personal Care recalls
Be the first to know. Free instant alerts to your inbox.
The recalled product is Sterile Water for Injection, 3000 mL, with NDC 0264-7385-60. The affected lot numbers include J3L519, J3L528, J4C522, and J4C523. The product was distributed nationwide in the U.S.
The recall stems from a lack of assurance of sterility, posing a high risk of contamination. Misalignment of the port can lead to fluid leakage, which may compromise patient safety.
As of now, there are no reported injuries or incidents associated with the recalled product. The FDA classified this recall as Class II.
Stop using the recalled Sterile Water for Injection immediately. Contact B. Braun Medical Inc. or your healthcare provider for further guidance.
For more information, visit the FDA website or contact B. Braun Medical Inc. at their customer service number.
Get instant alerts for recalls that affect you. Free forever.
Taro Pharmaceuticals announced a market withdrawal of Diclofenac Sodium, Topical Gel, 3% on January 27, 2026. The withdrawal stems from out of specification viscosity results. Healthcare providers and consumers should stop using the product immediately.
Fresenius Kabi Compounding recalled 1,057 bags of Acyclovir Sodium Injection on February 5, 2026. The recall stems from a lack of assurance of sterility, posing a high health risk. Healthcare providers should cease use immediately and contact the manufacturer for guidance.
Fresenius Kabi Compounding recalled its vancomycin HCl injection on February 5, 2026, due to a lack of assurance of sterility. This Class II recall affects all lots distributed nationwide. Healthcare providers and consumers must stop using the product immediately.
Fresenius Kabi Compounding recalled 1,578 bags of vancomycin HCl injection on February 5, 2026. The company cited a lack of assurance of sterility as the reason for the recall. Healthcare providers and consumers should stop using the product immediately.
Fresenius Kabi Compounding recalled 1,410 bags of ketamine HCl injection on February 5, 2026. The recall stems from a lack of assurance of sterility, posing a high health risk. Healthcare providers and consumers must stop using this product immediately.
Fresenius Kabi Compounding recalled 10,548 bags of thiamine HCl injection on February 5, 2026. The recall follows a lack of assurance of sterility, posing a high health risk. Affected products include several lots expiring between February and May 2026.
Pro Numb Tattoo Numbing Spray was recalled due to cGMP deviations. The recall affects products distributed nationwide in the USA. Consumers should stop using the spray immediately and contact Pro Numb Tattoo Numbing Spray LLC for guidance.
Pro Numb Tattoo Numbing Spray was recalled on February 2, 2026 due to cGMP deviations. The product, containing 4% lidocaine, is distributed by Pro Numb Tattoo Numbing Spray LLC. Consumers should stop using it immediately and contact the company for further guidance.